Angela Vincent Selected Research

Isaacs Syndrome (Neuromyotonia)

1/2020	ANTIBODIES AND RECEPTORS: From Neuromuscular Junction to Central Nervous System.
11/2019	Acquired neuromyotonia in children with CASPR2 and LGI1 antibodies.
12/2018	Association of Leucine-Rich Glioma Inactivated Protein 1, Contactin-Associated Protein 2, and Contactin 2 Antibodies With Clinical Features and Patient-Reported Pain in Acquired Neuromyotonia.
1/2017	Intracellular and non-neuronal targets of voltage-gated potassium channel complex antibodies.
11/2014	Axonal dysfunction with voltage gated potassium channel complex antibodies.
6/2014	Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre.
9/2010	Corticomotoneuronal function and hyperexcitability in acquired neuromyotonia.
9/2010	Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia.
5/2010	Autoimmune channelopathies: well-established and emerging immunotherapy-responsive diseases of the peripheral and central nervous systems.
1/2009	Immunotherapy responsive startle with antibodies to voltage gated potassium channels.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Angela Vincent Research Topics

Disease

86	Myasthenia Gravis 01/2022 - 01/2002
47	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 10/2006
40	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2018 - 06/2003
37	Seizures (Absence Seizure) 01/2021 - 09/2005
35	Neuromyelitis Optica (Devic's Disease) 12/2021 - 04/2007
30	Brain Diseases (Brain Disorder) 11/2018 - 03/2004
28	Epilepsy (Aura) 01/2019 - 06/2003
26	Glioma (Gliomas) 01/2020 - 09/2010
18	Isaacs Syndrome (Neuromyotonia) 01/2020 - 08/2002
17	Autoimmune Diseases (Autoimmune Disease) 12/2020 - 08/2002
16	Neoplasms (Cancer) 01/2016 - 08/2003
15	Psychotic Disorders (Schizoaffective Disorder) 12/2021 - 06/2011
14	Thymoma (Thymic Carcinoma) 11/2020 - 03/2003
13	Autoimmune Diseases of the Nervous System 01/2021 - 02/2014
13	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2020 - 03/2003
13	Multiple Sclerosis 05/2017 - 07/2003
12	Stiff-Person Syndrome (Stiff Man Syndrome) 11/2019 - 06/2003
11	Central Nervous System Diseases (CNS Diseases) 01/2022 - 05/2003
11	Inflammation (Inflammations) 01/2021 - 12/2007
11	Demyelinating Diseases (Demyelinating Disease) 07/2017 - 02/2010
10	Movement Disorders (Movement Disorder) 09/2020 - 10/2010
10	Myoclonus (Nocturnal Myoclonus) 11/2019 - 12/2011
9	Cognitive Dysfunction 01/2021 - 05/2011
8	Nervous System Diseases (Neurological Disorders) 10/2020 - 09/2008
8	Pain (Aches) 01/2020 - 05/2011
8	Progressive Encephalomyelitis with Rigidity 11/2019 - 12/2011
7	Arthrogryposis 01/2021 - 10/2002
7	Muscle Weakness 01/2020 - 02/2003
7	Atrophy 05/2017 - 06/2002
7	Complex Regional Pain Syndromes 01/2016 - 03/2005
6	Infections 01/2021 - 05/2011
6	Guillain-Barre Syndrome 10/2020 - 06/2009
6	Inborn Genetic Diseases (Disease, Hereditary) 01/2019 - 01/2002
6	Status Epilepticus (Complex Partial Status Epilepticus) 03/2016 - 11/2011
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2015 - 03/2003
5	Neurodevelopmental Disorders 08/2020 - 09/2002
5	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2016 - 04/2013
5	Transverse Myelitis (Necrotizing Myelitis) 04/2014 - 04/2007
4	Schizophrenia (Dementia Praecox) 01/2021 - 03/2005
4	Narcolepsy 09/2020 - 11/2013
4	Headache (Headaches) 01/2020 - 10/2011
4	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 10/2019 - 06/2002
4	Disease Progression 01/2019 - 08/2012
4	Dyskinesias (Dyskinesia) 01/2018 - 01/2012
4	Rhabdomyosarcoma 10/2017 - 01/2006
4	Partial Epilepsies (Epilepsy, Partial) 08/2014 - 06/2013
4	Leukocytosis (Pleocytosis) 05/2014 - 04/2009
4	Spasm (Spasms) 05/2014 - 10/2011
3	Autism Spectrum Disorder 08/2020 - 01/2017
3	Autistic Disorder (Autism) 08/2020 - 04/2003
3	Lymphocytosis 01/2020 - 06/2010

Drug/Important Bio-Agent (IBA)

220	AntibodiesIBA 01/2022 - 01/2002
101	AutoantibodiesIBA 06/2022 - 03/2002
66	Cholinergic ReceptorsIBA 01/2022 - 01/2002
57	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
55	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2021 - 04/2009
45	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2018 - 06/2002
36	muskIBA 01/2022 - 01/2002
35	Immunoglobulin G (IgG)IBA 01/2021 - 09/2003
26	AntigensIBA 01/2021 - 09/2002
25	Phosphotransferases (Kinase)IBA 01/2022 - 01/2002
24	Leucine (L-Leucine)FDA Link 01/2020 - 09/2010
20	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2017 - 03/2005
19	Glycine Receptors (Glycine Receptor)IBA 01/2020 - 08/2011
14	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019 - 09/2012
13	Ion Channels (Ion Channel)IBA 01/2018 - 10/2002
12	Calcium Channels (Calcium Channel)IBA 01/2020 - 06/2002
11	Complement System Proteins (Complement)IBA 01/2018 - 09/2007
10	N-Methylaspartate (NMDA)IBA 01/2022 - 06/2010
9	Potassium Channels (Potassium Channel)IBA 01/2020 - 06/2003
8	Intravenous Immunoglobulins (IVIG)FDA Link 10/2020 - 06/2003
8	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 10/2005
7	Surface Antigens (Surface Antigen)IBA 01/2021 - 01/2011
7	anti-leucine-rich glioma-inactivated 1 autoantibodyIBA 11/2019 - 05/2011
7	Glutamate Receptors (Glutamate Receptor)IBA 01/2018 - 06/2003
7	SteroidsIBA 05/2017 - 12/2005
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014 - 07/2004
6	Membrane Proteins (Integral Membrane Proteins)IBA 08/2020 - 04/2010
6	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018 - 05/2011
6	Aquaporins (Water Channels)IBA 01/2018 - 02/2010
6	anti-aquaporin 4 autoantibodyIBA 07/2017 - 11/2010
5	Aquaporin 4IBA 01/2018 - 04/2007
5	Oligoclonal BandsIBA 04/2015 - 06/2010
4	Antipsychotic Agents (Antipsychotics)IBA 12/2021 - 01/2013
4	peripheral membrane protein 43KIBA 01/2020 - 06/2002
4	Pharmaceutical PreparationsIBA 01/2020 - 10/2013
4	AcidsIBA 01/2019 - 12/2007
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2014
4	AgrinIBA 01/2016 - 01/2002
4	gamma-Aminobutyric Acid (GABA)IBA 08/2012 - 09/2010
3	Rituximab (Mabthera)FDA Link 12/2021 - 10/2010
3	Polytetrafluoroethylene (Teflon)FDA Link 01/2021 - 01/2018
3	Prednisone (Sone)FDA LinkGeneric 11/2020 - 11/2016
3	RNA (Ribonucleic Acid)IBA 10/2020 - 06/2002
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019 - 03/2009

Therapy/Procedure

49	Immunotherapy 01/2022 - 10/2003
11	Therapeutics 11/2020 - 06/2003
7	Plasma Exchange 12/2021 - 09/2008
4	Thymectomy 12/2020 - 11/2016
4	Immunomodulation 05/2017 - 04/2010